Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment'. Together they form a unique fingerprint.